Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 14

    1.

    Divergent Effects of alpha-Tocopherol and Vitamin C on the Generation of Dysfunctional HDL Associated with Diabetes and the Hp 2-2 Genotype.

    Asleh R, Levy AP.

    Antioxid Redox Signal. 2009 Dec 5. [Epub ahead of print]PMID: 19769483 [PubMed - as supplied by publisher]Related articles

    2.

    Haptoglobin: Basic and Clinical Aspects.

    Levy AP, Asleh R, Blum S, Levy NS, Miller-Lotan R, Kalet-Litman S, Anbinder Y, Lache O, Nakhoul FM, Asaf R, Farbstein D, Pollak M, Soloveichik YZ, Strauss M, Alshiek J, Livshits A, Schwartz A, Awad H, Jad K, Goldenstein H.

    Antioxid Redox Signal. 2009 Dec 5. [Epub ahead of print]PMID: 19659435 [PubMed - as supplied by publisher]Related articles

    3.

    Pharmacogenomic effect of vitamin E on kidney structure and function in transgenic mice with the haptoglobin 2-2 genotype and diabetes mellitus.

    Nakhoul FM, Miller-Lotan R, Awad H, Asleh R, Jad K, Nakhoul N, Asaf R, Abu-Saleh N, Levy AP.

    Am J Physiol Renal Physiol. 2009 Apr;296(4):F830-8. Epub 2009 Jan 28.PMID: 19176700 [PubMed - indexed for MEDLINE]Related articles

    4.

    Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype.

    Asleh R, Blum S, Kalet-Litman S, Alshiek J, Miller-Lotan R, Asaf R, Rock W, Aviram M, Milman U, Shapira C, Abassi Z, Levy AP.

    Diabetes. 2008 Oct;57(10):2794-800. Epub 2008 Jul 3.PMID: 18599520 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Hypothesis--haptoglobin genotype and diabetic nephropathy.

    Nakhoul FM, Miller-Lotan R, Awaad H, Asleh R, Levy AP.

    Nat Clin Pract Nephrol. 2007 Jun;3(6):339-44. Review.PMID: 17525716 [PubMed - indexed for MEDLINE]Related articles

    6.

    Downregulation of the hemoglobin scavenger receptor in individuals with diabetes and the Hp 2-2 genotype: implications for the response to intraplaque hemorrhage and plaque vulnerability.

    Levy AP, Purushothaman KR, Levy NS, Purushothaman M, Strauss M, Asleh R, Marsh S, Cohen O, Moestrup SK, Moller HJ, Zias EA, Benhayon D, Fuster V, Moreno PR.

    Circ Res. 2007 Jul 6;101(1):106-10. Epub 2007 May 24.PMID: 17525367 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease.

    Asleh R, Levy AP.

    Vasc Health Risk Manag. 2005;1(1):19-28. Review.PMID: 17319095 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Haptoglobin genotype determines myocardial infarct size in diabetic mice.

    Blum S, Asaf R, Guetta J, Miller-Lotan R, Asleh R, Kremer R, Levy NS, Berger FG, Aronson D, Fu X, Zhang R, Hazen SL, Levy AP.

    J Am Coll Cardiol. 2007 Jan 2;49(1):82-7. Epub 2006 Dec 13.PMID: 17207726 [PubMed - indexed for MEDLINE]Related articles

    9.

    Haptoglobin genotype is a regulator of reverse cholesterol transport in diabetes in vitro and in vivo.

    Asleh R, Miller-Lotan R, Aviram M, Hayek T, Yulish M, Levy JE, Miller B, Blum S, Milman U, Shapira C, Levy AP.

    Circ Res. 2006 Dec 8;99(12):1419-25. Epub 2006 Nov 2.PMID: 17082477 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction.

    Suleiman M, Aronson D, Asleh R, Kapeliovich MR, Roguin A, Meisel SR, Shochat M, Sulieman A, Reisner SA, Markiewicz W, Hammerman H, Lotan R, Levy NS, Levy AP.

    Diabetes. 2005 Sep;54(9):2802-6.PMID: 16123372 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Haptoglobin genotype- and diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo.

    Asleh R, Guetta J, Kalet-Litman S, Miller-Lotan R, Levy AP.

    Circ Res. 2005 Mar 4;96(4):435-41. Epub 2005 Jan 20.PMID: 15662028 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Serum chelatable redox-active iron is an independent predictor of mortality after myocardial infarction in individuals with diabetes.

    Sulieman M, Asleh R, Cabantchik ZI, Breuer W, Aronson D, Suleiman A, Miller-Lotan R, Hammerman H, Levy AP.

    Diabetes Care. 2004 Nov;27(11):2730-2. No abstract available. PMID: 15505013 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Tyrosine kinases inhibitors block Fas-mediated deleterious effects in normoxic and hypoxic ventricular myocytes.

    Shilkrut M, Yaniv G, Asleh R, Levy AP, Larisch S, Binah O.

    J Mol Cell Cardiol. 2003 Oct;35(10):1229-40.PMID: 14519433 [PubMed - indexed for MEDLINE]Related articles

    14.

    Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease.

    Asleh R, Marsh S, Shilkrut M, Binah O, Guetta J, Lejbkowicz F, Enav B, Shehadeh N, Kanter Y, Lache O, Cohen O, Levy NS, Levy AP.

    Circ Res. 2003 Jun 13;92(11):1193-200. Epub 2003 May 15.PMID: 12750308 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...